Aspirin (acetylsalicylic acid, ASA) is a nonsteroidal anti-inflammatory drug (NSAID) commonly found in households.
Overview and Clinical Importance
Aspirin (acetylsalicylic acid, ASA) is a nonsteroidal anti-inflammatory drug (NSAID) commonly found in households. While aspirin has therapeutic uses in veterinary medicine, cats are uniquely susceptible to aspirin toxicity due to their deficient hepatic conjugation pathways. This species-specific vulnerability makes aspirin toxicity a critical topic for the NAVLE examination.
Feline aspirin toxicity represents a classic example of how species-specific pharmacokinetics affect drug safety. Understanding the metabolic basis for feline sensitivity, recognizing clinical signs, and implementing appropriate treatment are essential competencies for veterinary practice.
High-YieldCats are 5-6 times more susceptible to aspirin toxicity than dogs. A single standard adult aspirin tablet (325 mg) given twice daily has been reported lethal in cats. The prolonged half-life of aspirin in cats (37.5 hours vs 8.6 hours in dogs) is the key to understanding this species' unique vulnerability.
| Enzyme |
Functions and Products |
| COX-1 (Constitutive) |
Gastroprotection: Stimulates gastric mucus and bicarbonate secretion
Renal perfusion: Maintains renal blood flow via prostaglandin vasodilation
Platelet function: Produces thromboxane A2 for platelet aggregation |
| COX-2 (Inducible) |
Inflammation: Produces PGE2 at sites of tissue injury
Pain/Fever: Mediates peripheral and central sensitization
Healing: Important for GI mucosal healing when damaged |
Mechanism of Action and Toxicity
Normal Aspirin Pharmacology
Aspirin exerts its effects through irreversible inhibition of cyclooxygenase (COX) enzymes. Unlike other NSAIDs that reversibly bind COX, aspirin covalently acetylates a serine residue (Ser-530) in the COX active site, permanently inactivating the enzyme.
COX Enzyme Functions
Why Cats Are Different: Metabolic Deficiency
The hallmark of feline aspirin toxicity lies in their deficient hepatic conjugation pathways. While historically attributed to glucuronidation deficiency, current evidence indicates that deficient glycine conjugation is the primary cause of prolonged aspirin clearance in cats.
Species Comparison: Aspirin Pharmacokinetics
NAVLE TipThe NAVLE commonly tests the concept that cats have a prolonged aspirin half-life (approximately 37-40 hours vs 8.6 hours in dogs). Remember: this is primarily due to deficient GLYCINE conjugation, not glucuronidation. Cats CAN glucuronidate salicylate–they just cannot form salicylurate efficiently.
Pathophysiology of Aspirin Toxicity
Aspirin toxicity in cats affects multiple organ systems through several interconnected mechanisms:
1. Gastrointestinal Effects
- Direct mucosal irritation (aspirin is acidic)
- Loss of protective prostaglandin-mediated gastroprotection
- Reduced mucosal blood flow and bicarbonate secretion
- Gastric and intestinal ulceration with potential perforation
2. Acid-Base Disturbances
- Early: Respiratory alkalosis (direct stimulation of medullary respiratory center)
- Late: Metabolic acidosis (uncoupling of oxidative phosphorylation, lactic acid accumulation)
- Mixed acid-base disorder is the classic presentation
3. Coagulopathy
- Irreversible platelet COX-1 inhibition (platelets cannot synthesize new COX)
- Decreased thromboxane A2 production
- Prolonged bleeding time for platelet lifespan (5-7 days)
4. Hepatic and Renal Effects
- Centrilobular hepatic necrosis at high doses
- Reduced renal blood flow from prostaglandin inhibition
- Acute kidney injury (especially in dehydrated or pre-existing renal disease patients)
5. Thermal Dysregulation
- Uncoupling of oxidative phosphorylation produces heat instead of ATP
- Hyperthermia is common in severe toxicosis
Exam Focus: Understand the sequence: Early respiratory alkalosis → Late metabolic acidosis → Mixed acid-base disorder. Hyperthermia results from uncoupling of oxidative phosphorylation, not fever.
| Parameter |
Cat |
Dog |
| Elimination Half-Life |
22-45 hours (dose-dependent) |
8.6 hours |
| Primary Metabolic Defect |
Deficient glycine conjugation (salicylurate formation) |
Normal conjugation |
| Glucuronidation Capacity |
Can glucuronidate salicylate (NOT the primary issue) |
Normal |
| Toxic Dose Threshold |
Greater than 25 mg/kg (signs possible at 10 mg/kg) |
100-300 mg/kg/day |
| Lethal Dose |
80 mg/kg; 325 mg BID reported lethal |
500+ mg/kg |
Common Exposure Scenarios
Sources of Aspirin/Salicylate Exposure
High-YieldPepto-Bismol contains bismuth SUBSALICYLATE. Never recommend Pepto-Bismol for cats with GI upset–this is a common owner mistake that leads to toxicity. Additionally, bismuth subsalicylate antacids are CONTRAINDICATED in aspirin toxicity treatment.
Risk Factors for Toxicity
- Pre-existing renal or hepatic disease: Impaired drug clearance
- Dehydration: Increased plasma concentrations, enhanced renal damage
- Concurrent NSAID or corticosteroid use: Potentiates GI toxicity
- Young or geriatric cats: Immature or declining hepatic/renal function
- Enteric-coated formulations: Unpredictable absorption, gastric retention
| Source |
Salicylate Content |
Risk Level |
| Regular aspirin tablet |
325 mg/tablet |
HIGH - One tablet toxic to cats |
| Baby aspirin |
81 mg/tablet |
MODERATE - Multiple tablets toxic |
| Pepto-Bismol (bismuth subsalicylate) |
8.7 mg salicylate/mL |
HIGH - Often given by owners |
| Oil of wintergreen (methyl salicylate) |
Highly concentrated |
VERY HIGH - Small amount lethal |
| Topical arthritis creams |
Variable |
MODERATE - Systemic absorption |
Clinical Signs
Clinical signs typically develop within 4-6 hours of acute ingestion, but may be delayed with enteric-coated products or chronic exposure.
Timeline of Clinical Signs
NAVLE TipThe classic early sign in cats is ANOREXIA, often before vomiting develops. On the NAVLE, look for a cat with sudden loss of appetite and owner-reported aspirin administration. Early respiratory alkalosis presents as tachypnea/hyperpnea.
Organ System-Specific Findings
| Phase/Timing |
Clinical Signs |
| Early (4-6 hours) |
Anorexia (often first sign), vomiting, depression, tachypnea (respiratory alkalosis) |
| Intermediate (12-24 hours) |
Hematemesis, melena, abdominal pain, hyperthermia, dehydration, weakness |
| Severe/Late (24-72+ hours) |
Ataxia, seizures, coma, acute kidney injury (oliguria/anuria), hepatic failure, bleeding diathesis, pale mucous membranes (anemia from GI blood loss or bone marrow suppression) |
| Chronic Toxicity (days-weeks) |
Gradual onset of GI ulceration, progressive renal dysfunction, bone marrow suppression, hepatopathy |
Diagnosis
Diagnosis is typically based on history of exposure combined with compatible clinical signs. A thorough history is essential, as owners may not volunteer aspirin administration or may not realize products contain salicylates.
Diagnostic Workup
Essential Diagnostics
Serum Salicylate Measurement
Serum salicylate levels can be measured through specialized laboratories to confirm exposure and guide treatment. Therapeutic salicylate levels in cats for antiplatelet effects are typically 20-50 mcg/mL. Levels above this range indicate toxicity. Serial measurements help monitor treatment response.
High-YieldThe hallmark acid-base finding in salicylate toxicity is a MIXED respiratory alkalosis with metabolic acidosis. This pattern should raise suspicion for aspirin toxicity even if no history is provided. Early toxicity shows respiratory alkalosis alone.
| System |
Clinical and Diagnostic Findings |
| Gastrointestinal |
Vomiting (with or without blood), hematemesis, melena, diarrhea, abdominal pain on palpation, gastric/intestinal ulceration |
| Respiratory |
Tachypnea, hyperpnea (respiratory alkalosis), pulmonary edema in severe cases |
| Neurological |
Depression, ataxia, weakness, tremors, seizures (severe toxicity), coma |
| Hematologic |
Prolonged bleeding time, anemia (GI blood loss), bone marrow suppression (chronic), pale mucous membranes |
| Renal |
Oliguria or polyuria, azotemia, isosthenuria, acute kidney injury |
| Hepatic |
Elevated liver enzymes (ALT, AST), icterus (severe cases), centrilobular necrosis |
Treatment
There is no specific antidote for aspirin toxicity. Treatment is supportive and focused on decontamination, enhancing elimination, protecting organ systems, and managing complications.
Treatment Algorithm
1. Decontamination (within 2-4 hours of ingestion)
2. Enhanced Elimination
3. Supportive Care and Symptomatic Treatment
Exam Focus: Key contraindications in aspirin toxicity treatment: (1) Bismuth subsalicylate antacids (contain salicylate), (2) Corticosteroids (potentiate GI damage), (3) Acetazolamide (worsens metabolic acidosis despite increasing urinary bicarbonate), (4) CNS/respiratory depressants (impair compensatory hyperventilation).
Monitoring Parameters
- Serum salicylate levels every 2-4 hours until declining
- Blood gas and electrolytes every 2-4 hours during alkalinization
- Urine pH every 2 hours (target 7.5-8.0)
- Renal values (BUN, creatinine) at 24, 48, and 72 hours
- Liver enzymes at 24 and 72 hours
- PCV/TP and coagulation panel as indicated
| Test |
Expected Findings in Toxicity |
| CBC |
Anemia (regenerative from GI blood loss), thrombocytopenia possible, bone marrow suppression with chronic exposure |
| Serum Chemistry |
Elevated BUN/creatinine, elevated liver enzymes (ALT, AST), hypoglycemia or hyperglycemia, electrolyte disturbances (hypokalemia), reduced total protein |
| Blood Gas Analysis |
Early: Respiratory alkalosis (decreased pCO2). Late: Metabolic acidosis (decreased bicarbonate, increased anion gap). Classic: Mixed respiratory alkalosis + metabolic acidosis |
| Urinalysis |
Acidic urine (despite respiratory alkalosis), glucosuria possible, decreased concentration (isosthenuria), salicylate metabolites detectable |
| Coagulation Panel |
Prolonged bleeding time (buccal mucosal bleeding time), PT/PTT usually normal unless hepatic failure |
Prognosis
Prognosis depends on the dose ingested, time to treatment, and presence of complications.
| Intervention |
Details |
| Emesis Induction |
Perform if recent ingestion (less than 2 hours) and patient is asymptomatic. Use dexmedetomidine (40 mcg/kg IM) or xylazine (0.44 mg/kg IM). CAUTION: Do not induce vomiting at home in cats–higher risk of aspiration. |
| Gastric Lavage |
Consider if large ingestion or enteric-coated product suspected. Perform under anesthesia with endotracheal tube in place. Useful if bezoar suspected (rising salicylate levels despite treatment). |
| Activated Charcoal |
1-2 g/kg PO with cathartic (sorbitol 70%: 1-2 mL/kg). May repeat charcoal without cathartic every 4-6 hours for large exposures (aspirin has enterohepatic recirculation). Administer within 4 hours of ingestion for best efficacy. |
Memory Aids
Mnemonic: "CATS ASPIRIN"
C - Conjugation deficient (glycine)
A - Anorexia is first sign
T - Thirty-seven hour half-life (37.5 hours)
S - Salicylate = aspirin metabolite
A - Acidosis (metabolic) develops late
S - Single tablet can be toxic (325 mg)
P - Prostaglandin inhibition (COX)
I - IV fluids 72+ hours
R - Respiratory alkalosis early
I - Increase urine pH (alkalinization)
N - No antidote exists
Quick Numbers to Remember
- 37.5 hours: Feline aspirin half-life (vs 8.6 hours in dogs)
- 5-6x: How much longer aspirin stays in cats vs dogs
- 25 mg/kg: Toxic threshold in cats
- 80 mg/kg: Lethal dose in cats
- 4-6 hours: Time to onset of clinical signs
- 72 hours: Minimum IV fluid duration
- 10-14 days: Duration of GI protectants
- 7.5-8.0: Target urine pH for alkalinization
| Method |
Protocol and Notes |
| Urinary Alkalinization |
Sodium bicarbonate: 1-2 mEq/kg IV slowly, then maintain urine pH 7.5-8.0. Alkaline urine traps ionized salicylate in tubular lumen, increasing urinary excretion by 10-20 fold. MONITOR: Serum potassium (hypokalemia worsens with alkalinization), serum pH, urine pH every 2 hours. |
| IV Fluid Therapy |
Crystalloids (LRS or 0.9% NaCl) at 2-3x maintenance for at least 72 hours (due to prolonged half-life). Correct dehydration. Maintain urine output. Support renal perfusion. |
| Hemodialysis/Peritoneal Dialysis |
Consider for severe toxicity with: Refractory acidosis, acute renal failure, severe neurological signs (seizures, coma), patients intolerant of fluid therapy, very high salicylate levels. |
| Complication |
Treatment |
| GI Ulceration/Protection |
Sucralfate: 0.25-0.5 g PO q8-12h (binds to damaged mucosa). H2 blockers: Famotidine 0.5-1 mg/kg IV/PO q12-24h. Proton pump inhibitors: Omeprazole 1 mg/kg PO q24h. Continue GI protectants for 10-14 days. |
| Vomiting |
Maropitant: 1 mg/kg SC/IV q24h. Ondansetron: 0.5-1 mg/kg IV q12h for severe cases. |
| Seizures |
Diazepam: 0.5-1 mg/kg IV to effect. Levetiracetam: 20-60 mg/kg IV loading dose if refractory. |
| Hyperthermia |
External cooling measures (cool IV fluids, fans, alcohol on paw pads). Avoid antipyretics (they work on prostaglandins). |
| Bleeding/Coagulopathy |
Blood transfusion (pRBCs or whole blood) for significant anemia. Fresh frozen plasma if coagulopathy. |
| Hepatic Support |
SAMe (S-adenosylmethionine): 20 mg/kg PO q24h. N-acetylcysteine: 140 mg/kg IV loading, then 70 mg/kg IV q6h x 7 doses. Vitamin C (ascorbic acid) as adjunct. |
| Scenario |
Expected Outcome |
| Early treatment (less than 12 hours) |
Good to excellent prognosis with appropriate decontamination and supportive care |
| Moderate toxicity |
Fair to good with aggressive treatment; GI ulceration typically resolves with gastroprotectants |
| Severe toxicity with AKI |
Guarded to poor; some cats recover with intensive support including dialysis |
| Neurological signs (seizures/coma) |
Poor; indicates severe CNS toxicity and often concurrent organ failure |